Sitkovsky M - Search Results

1

The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells.

Hatfield S, Belikoff B, Lukashev D, Sitkovsky M, Ohta A. Hatfield S, et al. Among authors: sitkovsky m. J Leukoc Biol. 2009 Sep;86(3):545-8. doi: 10.1189/jlb.0908577. Epub 2009 Jun 29. J Leukoc Biol. 2009. PMID: 19564571 Free PMC article. Review.

2

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.

Sitkovsky M, Lukashev D. Sitkovsky M, et al. Nat Rev Immunol. 2005 Sep;5(9):712-21. doi: 10.1038/nri1685. Nat Rev Immunol. 2005. PMID: 16110315 Review.

3

1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism.

Ohta A, Lukashev D, Jackson EK, Fredholm BB, Sitkovsky M. Ohta A, et al. Among authors: sitkovsky m. J Immunol. 2007 Dec 1;179(11):7431-8. doi: 10.4049/jimmunol.179.11.7431. J Immunol. 2007. PMID: 18025187

4

Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytes.

Lukashev D, Sitkovsky M. Lukashev D, et al. Among authors: sitkovsky m. Hum Immunol. 2008 Jul;69(7):421-5. doi: 10.1016/j.humimm.2008.05.004. Epub 2008 Jun 11. Hum Immunol. 2008. PMID: 18638657 Free PMC article.

5

The adenosinergic immunomodulatory drugs.

Ohta A, Sitkovsky M. Ohta A, et al. Among authors: sitkovsky m. Curr Opin Pharmacol. 2009 Aug;9(4):501-6. doi: 10.1016/j.coph.2009.05.005. Epub 2009 Jun 17. Curr Opin Pharmacol. 2009. PMID: 19539527 Free PMC article. Review.

6

Methylxanthines, inflammation, and cancer: fundamental mechanisms.

Ohta A, Sitkovsky M. Ohta A, et al. Among authors: sitkovsky m. Handb Exp Pharmacol. 2011;(200):469-81. doi: 10.1007/978-3-642-13443-2_19. Handb Exp Pharmacol. 2011. PMID: 20859809 Review.

7

Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Sitkovsky M, Ohta A. Sitkovsky M, et al. J Mol Med (Berl). 2013 Feb;91(2):147-55. doi: 10.1007/s00109-013-1001-9. Epub 2013 Jan 20. J Mol Med (Berl). 2013. PMID: 23334369 Free PMC article. Review.

8

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Hatfield SM, Kjaergaard J, Lukashev D, Belikoff B, Schreiber TH, Sethumadhavan S, Abbott R, Philbrook P, Thayer M, Shujia D, Rodig S, Kutok JL, Ren J, Ohta A, Podack ER, Karger B, Jackson EK, Sitkovsky M. Hatfield SM, et al. Among authors: sitkovsky m. J Mol Med (Berl). 2014 Dec;92(12):1283-92. doi: 10.1007/s00109-014-1189-3. Epub 2014 Aug 15. J Mol Med (Berl). 2014. PMID: 25120128 Free PMC article.

9

A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.

Hatfield SM, Sitkovsky M. Hatfield SM, et al. Among authors: sitkovsky m. Curr Opin Pharmacol. 2016 Aug;29:90-6. doi: 10.1016/j.coph.2016.06.009. Epub 2016 Jul 17. Curr Opin Pharmacol. 2016. PMID: 27429212 Free PMC article. Review.

10

A_2A Adenosine Receptor Gene Deletion or Synthetic A_2A Antagonist Liberate Tumor-Reactive CD8⁺ T Cells from Tumor-Induced Immunosuppression.

Kjaergaard J, Hatfield S, Jones G, Ohta A, Sitkovsky M. Kjaergaard J, et al. Among authors: sitkovsky m. J Immunol. 2018 Jul 15;201(2):782-791. doi: 10.4049/jimmunol.1700850. Epub 2018 May 25. J Immunol. 2018. PMID: 29802128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters